Common obstacles in lipid management.
This article provides the health care practitioner with some viable options to consider when starting a treatment plan for patients who have hyperlipidemia. These suggestions may increase patient compliance rates.
Elpers
Missie
M
The Heart Group, 415 West Columbia Street, Evansville, Indiana 47710, USA. missie22@heartgroup.com
D016903:Drug Monitoring; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D010347:Patient Care Planning; D010349:Patient Compliance
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents